Filing Details

Accession Number:
0001399529-21-000150
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 18:48:17
Reporting Period:
2021-09-15
Accepted Time:
2021-09-17 18:48:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA Pharmaceutical Preparations (2834) 205993609
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1824252 Ling Zeng C/O Dicerna Pharmaceuticals, Inc.
75 Hayden Avenue
Lexington MA 02421
Chief Legal Officer & Sec'y No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-15 4,556 $0.00 4,556 No 4 M Direct
Common Stock Disposition 2021-09-17 1,334 $21.47 3,222 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-09-15 4,556 $0.00 4,556 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,669 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
  2. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs and does not represent a discretionary trade by the Reporting Person.
  3. Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date